POLYMERIC NANO-CARRIERS FOR DRUG DELIVERY SYSTEMS IN CANCER THERAPY - AN EXHAUSTIVE REVIEW
Keywords:
Drug delivery systems, Nanoparticles, Nanocarriers, Tumor, Chemotherapy, PharmacokineticsAbstract
Progress in molecular pharmacology and a better comprehension of the mechanism of various diseases have necessitated the precise targeting of the cells responsible for initiating and advancing these diseases. This is particularly applicable to the majority of life-threatening illnesses that necessitate treatment medicines with multiple adverse effects. Therefore, precise tissue targeting is necessary to minimize systemic exposure. Modern drug delivery systems (DDS) are developed utilizing cutting-edge technology to expedite the administration of drugs across the body to a particular target area, optimizing the effectiveness of the treatment and reducing the buildup of drugs in unintended areas of the body. Consequently, they significantly impact the management and treatment of diseases. Modern drug delivery systems (DDS) provide significant advantages over traditional methods. These include improved performance, automation, precision, and efficacy. They consist of nanomaterials or miniaturized devices that comprise multifunctional components. These components are biocompatible, biodegradable, and possess high viscoelasticity, resulting in a longer circulating half-life. This article thoroughly examines the history and technological progress of medication delivery systems. The text provides an update on the latest advancements in drug delivery systems, including their therapeutic applications used in Cancer, their present obstacles, and potential future improvements for enhanced performance and utilization.
Downloads
References
Vaidhya RRB and IS. novel drug delivery systems: an overview. Int J Pharm Sci Res. 2013;4(3):970-982.
Tobechukwu Christian Ezike a, b, Ugochukwu Solomon Okpala a,*, Ufedo Lovet Onoja a, Chinenye Princess Nwike a, Emmanuel Chimeh Ezeako a, Osinachi Juliet Okpara a, Charles Chinkwere Okoroafor a, Shadrach Chinecherem Eze c, Onyinyechi Loveth Kalu c, Evarist B, Okoroafor CC, Eze SC, Kalu OL, Odoh EC, Nwadike UG, et al. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023;9(6):e17488. doi:10.1016/j.heliyon.2023.e17488
DONATELLA PAOLINO MASSIMO FRESTA, PIYUSH SINHA MF. Drug delivery systems. In: Encyclopedia of Medical Devices and Instrumentation. ; 2006:437-493. doi:10.1007/978-981-13-0152-0_9.
Tiwari G, Tiwari R, Bannerjee S, Bhati L, Pandey S, Pandey P, et al. Drug delivery systems: An updated review. Int J Pharm Investig. 2012;2(1):2. doi:10.4103/2230-973x.96920
Kumar JP, Ismail Y, Reddy KTK, Panigrahy UP, Shanmugasundaram P, Babu MK. Paclitaxel Nanosponges’ Formula and in Vitro Evaluation. J Pharm Negat Results. 2022;13(7):2733-2740. doi:10.47750/pnr.2022.13.S07.365
Sakshi RKS. “Liposomes - An Updated overview.” Int J PHARMA Prof Res. 2024;15(1):119-127.
KSHIRSAGAR NA. Drug delivery systems. Indian J Pharmacol. 2000;32(2):S54-S61.
Ramakrishna SA* and S. Controlled Drug Delivery Systems : Current Status and Future Directions. Molecules. 2021;26:5905. doi:https://doi.org/10.3390/molecules26195905
Debjit Bhowmik 1*, Harish Gopinath 1, B. Pragati Kumar 1, S. Duraivel 1 KPSK 2. Controlled release drug delivery systems. Pharma Innov. 2012;1(10):24-32. doi:10.1080/10837450.2018.1534376
Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, et al. Nano based drug delivery systems: Recent developments and future prospects. J Nanobiotechnology. 2018;16(71):1-33. doi:10.1186/s12951-018-0392-8
Zhang JJ, Xu QJ, Zhang Y, Zhou Q, Lv R, Chen Z, et al. Recent advances in nanocarriers for clinical platinum(II) anticancer drugs. Coord Chem Rev. 2024;505(January):215676. doi:10.1016/j.ccr.2024.215676
Jafarzadeh F, Peyman H, Roshanfekr H, Azizi S, Idris AO, Maaza M. Fabrication of a Nanomagnetic Smart Polymer Carrier as a Potential Candidate for a Drug Delivery System. Arab J Sci Eng. 2024;49(7):9381-9394. doi:10.1007/s13369-024-08724-0
Al Alabdullah MAA, Goodarzi MT, Homayouni Tabrizi M. The silibinin-loaded Zein-β cyclodextrin nano-carriers (SZBC-NCs) as a novel selective cancer cell drug delivery system in HT-29 cell line. Sci Rep. 2024;14(1):1-9. doi:10.1038/s41598-024-65881-w
Ulldemolins A, Seras-Franzoso J, Andrade F, Rafael D, Abasolo I, Gener P, et al. Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics. Cancer Drug Resist. 2021;4(1):44-68. doi:10.20517/cdr.2020.59
Blair H. Types of Drug Delivery System and Drug Therapies. J Dev Drugs. 2022;11(3):1-2. doi:10.35248/2329-6631.22.11.171.Citation
Ranjan Kumar Singh, J Pavan Kumar, Chennu MM Prasada Rao, Rajeswari Tannairu, and Ajay Garg. “recent developments in quercetin-loaded nanoparticles for cancer targeting”. Tropical Journal of Pharmaceutical and Life Sciences, vol. 12, no. 1, Feb. 2025, pp. 11-23, doi:10.61280/tjpls.v12i1.174.
Yu J, Qiu H, Yin S, Wang H, Li Y. Polymeric drug delivery system based on pluronics for cancer treatment. Molecules. 2021;26(12):1-23. doi:10.3390/molecules26123610
Kumar JP, Rao CMMP, Singh RK, Garg A. A brief review on encapsulation of natural poly-phenolic compounds. Adv Pharm J. 2024;9(April):33-39. doi:10.31024/apj.2024.9.2.1
Pavan Kumar J, Prasada Rao CM, Singh RK, Garg A, Rajeswari T. A Comprehensive Guide to Hydrogel-Based Controlled Drug Delivery for Cancer Treatment. J Drug Deliv Ther. 2024;14(8):195-200. doi:10.22270/jddt.v14i8.6732
J Pavan Kumar, Chennnu MM Prasada Rao, Ranjan Kumar Singh, Ajay Garg, Tanniru Rajeswari. A comprehensive review on blood brain delivery methods using nanotechnology. Trop J Pharm Life Sci. 2024;11(3):43-59. doi:10.61280/tjpls.v11i3.162.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Tropical Journal of Pharmaceutical and Life Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.